StockData
Nephros Inc logo

Nephros Inc (NEPH) stock

NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3024% below fair value
$2.89−0.01 (-0.34%)

Close on Nov 18, 2026Market cap $31.39MP/E 18.1Yield –

Nephros gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Nephros's gross profit for the twelve months ending Jun 30, 2026 was $12.70M, up 20.1% year over year. For fiscal 2025 it was $11.63M, up 33.3% from the year before. Over ten years it grew 27.1% a year on average. The highest annual figure on record is $11.63M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.63M+33.3%
FY2024Dec 31, 2024$8.72M+3.8%
FY2023Dec 31, 2023$8.41M+77.7%
FY2022Dec 31, 2022$4.73M-16.0%
FY2021Dec 31, 2021$5.63M+14.7%
FY2020Dec 31, 2020$4.91M-19.2%
FY2019Dec 31, 2019$6.08M+89.9%
FY2018Dec 31, 2018$3.20M+39.7%
FY2017Dec 31, 2017$2.29M+77.1%
FY2016Dec 31, 2016$1.29M+22.1%
FY2015Dec 31, 2015$1.06M-11.6%
FY2014Dec 31, 2014$1.20M+42.4%
FY2013Dec 31, 2013$842.00K-21.3%
FY2012Dec 31, 2012$1.07M+23.3%
FY2011Dec 31, 2011$868.00K-22.6%
FY2010Dec 31, 2010$1.12M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.03M+44.0%
Q1 FY2026Mar 31, 2026$2.99M-5.1%
Q4 FY2025Dec 31, 2025$2.76M+11.6%
Q3 FY2025Sep 30, 2025$2.92M+35.6%
Q2 FY2025Jun 30, 2025$2.80M+46.2%
Q1 FY2025Mar 31, 2025$3.15M+44.2%
Q4 FY2024Dec 31, 2024$2.48M+22.5%
Q3 FY2024Sep 30, 2024$2.15M-2.1%
Q2 FY2024Jun 30, 2024$1.91M-8.0%
Q1 FY2024Mar 31, 2024$2.19M+3.6%
Q4 FY2023Dec 31, 2023$2.02M+33.9%
Q3 FY2023Sep 30, 2023$2.19M+187.9%
Q2 FY2023Jun 30, 2023$2.08M+49.0%
Q1 FY2023Mar 31, 2023$2.11M+100.5%
Q4 FY2022Dec 31, 2022$1.51M+2.6%
Q3 FY2022Sep 30, 2022$762.00K-44.0%
Q2 FY2022Jun 30, 2022$1.40M+9.4%
Q1 FY2022Mar 31, 2022$1.05M-33.6%
Q4 FY2021Dec 31, 2021$1.47M+13.0%
Q3 FY2021Sep 30, 2021$1.36M+11.0%
Q2 FY2021Jun 30, 2021$1.28M+42.5%
Q1 FY2021Mar 31, 2021$1.59M+6.4%
Q4 FY2020Dec 31, 2020$1.30M-31.5%
Q3 FY2020Sep 30, 2020$1.23M-32.7%
Q2 FY2020Jun 30, 2020$895.00K-34.5%
Q1 FY2020Mar 31, 2020$1.49M+49.4%
Q4 FY2019Dec 31, 2019$1.90M+99.2%
Q3 FY2019Sep 30, 2019$1.82M+91.1%
Q2 FY2019Jun 30, 2019$1.37M+64.7%
Q1 FY2019Mar 31, 2019$998.00K+113.7%
Q4 FY2018Dec 31, 2018$954.00K+21.1%
Q3 FY2018Sep 30, 2018$952.00K+78.9%
Q2 FY2018Jun 30, 2018$830.00K+60.5%
Q1 FY2018Mar 31, 2018$467.00K+2.6%
Q4 FY2017Dec 31, 2017$788.00K+104.1%
Q3 FY2017Sep 30, 2017$532.00K+68.4%
Q2 FY2017Jun 30, 2017$517.00K–
Q1 FY2017Mar 31, 2017$455.00K–
Q4 FY2016Dec 31, 2016$386.00K–
Q3 FY2016Sep 30, 2016$316.00K–

More Nephros figures

See a number that looks wrong?